SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
E2F5 | hg19_v2_chr8_+_86089460_86089483 | 0.96 | 4.1e-11 | Click! |
E2F2 | hg19_v2_chr1_-_23857698_23857733 | 0.92 | 7.7e-09 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_64673630 Show fit | 21.78 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101 |
|
chr20_-_32274179 Show fit | 19.76 |
ENST00000343380.5
|
E2F transcription factor 1 |
|
chr1_-_23857698 Show fit | 19.59 |
ENST00000361729.2
|
E2F transcription factor 2 |
|
chr15_+_32907691 Show fit | 19.34 |
ENST00000361627.3
ENST00000567348.1 ENST00000563864.1 ENST00000543522.1 |
Rho GTPase activating protein 11A |
|
chr15_-_64673665 Show fit | 19.09 |
ENST00000300035.4
|
KIAA0101 |
|
chr8_-_124408652 Show fit | 18.37 |
ENST00000287394.5
|
ATPase family, AAA domain containing 2 |
|
chr7_+_94285637 Show fit | 18.35 |
ENST00000482108.1
ENST00000488574.1 |
paternally expressed 10 |
|
chr7_-_94285472 Show fit | 18.01 |
ENST00000437425.2
ENST00000447873.1 ENST00000415788.2 |
sarcoglycan, epsilon |
|
chr7_-_94285402 Show fit | 17.99 |
ENST00000428696.2
ENST00000445866.2 |
sarcoglycan, epsilon |
|
chr7_-_94285511 Show fit | 17.79 |
ENST00000265735.7
|
sarcoglycan, epsilon |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 87.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
5.5 | 71.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 45.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
7.9 | 39.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
5.0 | 35.0 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
4.4 | 30.8 | GO:0060356 | leucine import(GO:0060356) |
1.8 | 25.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
5.8 | 23.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
1.6 | 23.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 21.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 113.4 | GO:0042555 | MCM complex(GO:0042555) |
5.4 | 53.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.3 | 49.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 47.5 | GO:0005667 | transcription factor complex(GO:0005667) |
7.0 | 35.0 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.5 | 32.8 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.8 | 31.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 30.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 24.1 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 23.3 | GO:0005874 | microtubule(GO:0005874) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 66.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 47.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 44.6 | GO:0004386 | helicase activity(GO:0004386) |
1.0 | 37.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 36.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.4 | 35.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.5 | 30.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 28.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 23.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
3.9 | 23.3 | GO:0051870 | methotrexate binding(GO:0051870) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 70.8 | PID ATR PATHWAY | ATR signaling pathway |
3.0 | 48.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 45.2 | PID E2F PATHWAY | E2F transcription factor network |
1.5 | 39.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 36.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 29.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 29.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 20.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.8 | 19.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 15.6 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.7 | 133.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
3.5 | 112.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.4 | 32.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.5 | 30.8 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.9 | 29.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.0 | 23.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 22.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
2.4 | 21.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.9 | 20.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 20.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |